As of 2024-07-27, the Relative Valuation of bluebird bio Inc (BLUE) is (14.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.22 USD, the upside of bluebird bio Inc based on Relative Valuation is -1316.4%.
The range of the Relative Valuation is (14.76) - (14.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.8x - 31.8x | 31.3x |
| Forward P/E multiples | 30.1x - 31.2x | 30.6x |
| Fair Price | (14.76) - (14.95) | (14.84) |
| Upside | -1309.5% - -1325.2% | -1316.4% |
| Date | P/E |
| 2024-07-26 | -2.55 |
| 2024-07-25 | -2.50 |
| 2024-07-24 | -2.40 |
| 2024-07-23 | -2.59 |
| 2024-07-22 | -2.38 |
| 2024-07-19 | -2.19 |
| 2024-07-18 | -2.40 |
| 2024-07-17 | -2.55 |
| 2024-07-16 | -2.82 |
| 2024-07-15 | -2.76 |
| 2024-07-12 | -2.55 |
| 2024-07-11 | -2.36 |
| 2024-07-10 | -2.17 |
| 2024-07-09 | -2.09 |
| 2024-07-08 | -1.95 |
| 2024-07-05 | -1.93 |
| 2024-07-03 | -1.91 |
| 2024-07-02 | -1.93 |
| 2024-07-01 | -2.04 |
| 2024-06-28 | -2.05 |
| 2024-06-27 | -1.98 |
| 2024-06-26 | -1.89 |
| 2024-06-25 | -1.98 |
| 2024-06-24 | -2.13 |
| 2024-06-21 | -1.88 |
| 2024-06-20 | -1.78 |
| 2024-06-18 | -1.90 |
| 2024-06-17 | -1.99 |
| 2024-06-14 | -2.00 |
| 2024-06-13 | -2.09 |
| 2024-06-12 | -2.06 |
| 2024-06-11 | -2.06 |
| 2024-06-10 | -1.95 |
| 2024-06-07 | -1.89 |
| 2024-06-06 | -1.91 |
| 2024-06-05 | -1.98 |
| 2024-06-04 | -2.02 |
| 2024-06-03 | -2.01 |
| 2024-05-31 | -1.89 |
| 2024-05-30 | -1.87 |
| 2024-05-29 | -1.88 |
| 2024-05-28 | -1.96 |
| 2024-05-24 | -2.02 |
| 2024-05-23 | -2.02 |
| 2024-05-22 | -2.05 |
| 2024-05-21 | -2.08 |
| 2024-05-20 | -2.15 |
| 2024-05-17 | -2.15 |
| 2024-05-16 | -2.19 |
| 2024-05-15 | -2.23 |